Symptoms can vary depending on where blood clots form and can be life-threatening in severe cases.
Thrombotic APS (blood clots):
• Deep vein thrombosis (DVT) – this occurs when blood clots develop in the veins in the limbs, leading to swelling, redness, and pain. The calves are most commonly affected.
• Pulmonary embolism – blood clots develop in the major artery (pulmonary artery) in the lungs. Patients may have shortness of breath, chest pain, raised heart rate and cough up blood. This can occur in tandem with DVT or as separate conditions. In severe cases, large pulmonary embolisms can lead to low blood pressure which can be dangerous.
• Stroke – blood clots develop in the arteries in the brain, and may lead to sudden numbness or weakness affecting one side of the body, double vision, incoordination or speech difficulties.
• Heart attack – blood clots in the major arteries supplying the heart (coronary arteries) can lead to a heart attack. Patients may present with chest pain, breathlessness, nausea and sweating.
• Blood clots may also occur in other parts of the body such as the blood vessels in the eyes, kidneys, liver and spleen.
APS is diagnosed based on both clinical history and blood tests showing specific antiphospholipid antibodies. A detailed history and clinical examination will be performed. Investigations include:
• Blood tests including blood counts, kidney and liver tests and antiphospholipid antibodies (aPLs) – repeated at least 12 weeks apart. These aPLs include:
o Lupus anticoagulant
o Anticardiolipin antibodies (IgM and IgG)
o Anti-beta-2 glycoprotein I antibodies (IgM and IgG)
• Imaging scans may be performed if there are suggestive symptoms to detect clots (such as ultrasound, CT or MRI)
Presence of antiphospholipid antibodies without any history of blood clots or pregnancy complications is not confirmatory for APS.
As APS can occur with other autoimmune conditions such as SLE, further tests for other autoimmune conditions may be performed as appropriate depending on clinical suspicion.
There is no cure for APS at present, but it can be well managed with medications and lifestyle modifications.
Thrombotic APS
• Patients with thrombotic APS will require long-term blood thinning medications (anticoagulation) to reduce the risk of recurrent blood clots.
o Warfarin is the most common medication used in APS. Regular blood tests will be performed to monitor warfarin levels (known as the international normalised ratio or INR) to ensure that the blood is not too thick or thin. Patients should maintain a consistent diet when taking warfarin as certain food can affect INR levels. Some medications and traditional herbs may also interact with warfarin and cause fluctuations in the INR. It is important to inform your healthcare providers that you are taking warfarin before starting any new medications as closer INR monitoring and dose adjustments may be required.
o Some patients may require heparin, a blood thinning medication given as injections under the skin (subcutaneous injection) when they are first started on warfarin, planned for any surgical procedures, or if they are unable to take warfarin.
• Aspirin (another blood thinning medication) may be added for certain patients with major blood clots in the arteries such as previous heart attack or strokes.
• Immune suppression medications may be required for patients with other autoimmune conditions in addition to APS
Obstetric APS
Patients with obstetric APS (pregnancy complications without any blood clots) do not require long-term anticoagulants except during pregnancy and in the first few weeks after delivery. Please see section below for more information.